Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Ross Carter currently holds 416,405 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Ross Carter has been a net neutral trader of TOI stock. They have purchased $0 and sold $0 worth of shares.
Robert Ross Carter's most recent insider trade was on Mar 27, 2026, when they sold 20,320 shares at $3.07 per share.
Robert Ross Carter serves as Executive at Oncology Institute, Inc. (TOI). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Robert Ross Carter holds the position of Executive at Oncology Institute, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Robert Ross Carter has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Robert Ross Carter was on Mar 27, 2026, when they sold $62.4K worth of TOI shares. This transaction involved 20,320 shares at $3.07 per share.
Robert Ross Carter currently owns 416,405 shares of Oncology Institute, Inc. (TOI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Ross Carter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Ross Carter has 3 Form 4 filings on record as an insider at Oncology Institute, Inc..
Set alerts for Robert Ross Carter and 40,000+ other insiders.